WHO, UNICEF, Pharma Meet On Supply Chains And Medicines Access 20/08/2018 William New The World Health Organization, UNICEF, and member companies of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) will meet this week at WHO in Geneva to discuss global and regional supply chain strategies and initiatives related to global health. Continue reading -> Wrong Diagnosis, Medication Errors, Care-Related Infections Adding USD 1 Trillion To Spiraling Health Costs Globally, Warn OECD, WHO, World Bank 24/07/2018 John Zarocostas The delivery of poor quality health services is spiraling health costs globally and holding back progress in improving health in both developing and rich nations alike warns a joint report by the OECD, World Health Organization, and the World Bank. Continue reading -> Top WHO Official On HIV/AIDS Gottfried Hirnschall: World Needs New Approaches To Deal With HIV/AIDS Challenges 23/07/2018 John Zarocostas As the 2018 International AIDS Conference kicks off in Amsterdam (23-27 July), Gottfried Hirnschall, Director of the HIV/AIDS Department and the Global Hepatitis Programme of the World Health Organization, discussed in a wide-ranging interview with John Zarocostas for Health Policy Watch the advances, setbacks, and challenges ahead in the global fight against the HIV/AIDS epidemic. On 18 July, a new report by UNAIDS warned that new infections are rising in around 50 countries, and that AIDS-related deaths are not falling fast enough and flat resources are threatening success. Dr Hirnschall leads the WHO's work in development and implementation of cutting-edge normative policies and guidance, and of technical support to countries to scale up national responses to HIV and hepatitis. He also oversees the Global Hepatitis Programme, which coordinates the organisation’s response to viral hepatitis. Hirnschall holds an MD from the University of Vienna, Austria, and an MPH from the Johns Hopkins Bloomberg School of Public Health. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> UN Debates Human Rights Issues Surrounding Mental And Physical Health Of Confined Persons 25/06/2018 Adithi Koushik The UN Human Rights Council session last week saw mental health placed at the forefront with the report of the Special Rapporteur on the Right to Health. Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Big Drop In AIDS-Related Deaths But Uneven Progress On Ending Disease, UN Says 14/06/2018 David Branigan Member states of the United Nations highlighted progress on combatting AIDS at a 12 June meeting of the General Assembly, with AIDS-related deaths reduced “from 1.5 million in 2010 to 1 million in 2016,” according to a UN report. But the report found progress toward eliminating the disease to be uneven, and provided recommendations to address gaps and challenges. Continue reading -> WHA: Africa Takes Steps For Access To Medicines – Conference To Fight Fakes, Develop Local Production 23/05/2018 Catherine Saez A week after African ministers of health adopted a treaty for the establishment on the African Medicines Agency, an international conference held on the side of the World Health Assembly denounced the rampant and increasing issue of fake medicines in Africa, and the lack of adequate action and political will. The Benin president said Benin's efforts to fight traffickers is so far unsupported, and called developed countries to commit to the fight. Other speakers insisted on the importance of local production of medicines, and the need for biting legislation to defeat fake medicines. Continue reading -> 50 Years Of Global Health Progress – Interview With IFPMA Head Thomas Cueni 23/05/2018 William New Dr Tedros Adhanom Ghebreyesus, WHO Director-General in his inaugural speech at the World Health Assembly this week, explained that partnerships are a key strategy for the WHO to ensuring healthy lives and promoting well-being for all at all ages. He added that the WHO is engaging with the private sector as a crucial partner in achieving health for all. Thomas Cueni, IFPMA’s Director General, in an interview with Health Policy Watch on the occasion of the IFPMA’s 50-year anniversary, explains how the research-based biopharmaceutical industry together with IFPMA have contributed to the huge strides in health progress over 50 years. He explains the major leaps forward, setbacks and mistakes, as well as how industry is part of the solution, as "do-ers" and partners in global health progress. Cueni also talks about pricing and cost of R&D. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Wrong Diagnosis, Medication Errors, Care-Related Infections Adding USD 1 Trillion To Spiraling Health Costs Globally, Warn OECD, WHO, World Bank 24/07/2018 John Zarocostas The delivery of poor quality health services is spiraling health costs globally and holding back progress in improving health in both developing and rich nations alike warns a joint report by the OECD, World Health Organization, and the World Bank. Continue reading -> Top WHO Official On HIV/AIDS Gottfried Hirnschall: World Needs New Approaches To Deal With HIV/AIDS Challenges 23/07/2018 John Zarocostas As the 2018 International AIDS Conference kicks off in Amsterdam (23-27 July), Gottfried Hirnschall, Director of the HIV/AIDS Department and the Global Hepatitis Programme of the World Health Organization, discussed in a wide-ranging interview with John Zarocostas for Health Policy Watch the advances, setbacks, and challenges ahead in the global fight against the HIV/AIDS epidemic. On 18 July, a new report by UNAIDS warned that new infections are rising in around 50 countries, and that AIDS-related deaths are not falling fast enough and flat resources are threatening success. Dr Hirnschall leads the WHO's work in development and implementation of cutting-edge normative policies and guidance, and of technical support to countries to scale up national responses to HIV and hepatitis. He also oversees the Global Hepatitis Programme, which coordinates the organisation’s response to viral hepatitis. Hirnschall holds an MD from the University of Vienna, Austria, and an MPH from the Johns Hopkins Bloomberg School of Public Health. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> UN Debates Human Rights Issues Surrounding Mental And Physical Health Of Confined Persons 25/06/2018 Adithi Koushik The UN Human Rights Council session last week saw mental health placed at the forefront with the report of the Special Rapporteur on the Right to Health. Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Big Drop In AIDS-Related Deaths But Uneven Progress On Ending Disease, UN Says 14/06/2018 David Branigan Member states of the United Nations highlighted progress on combatting AIDS at a 12 June meeting of the General Assembly, with AIDS-related deaths reduced “from 1.5 million in 2010 to 1 million in 2016,” according to a UN report. But the report found progress toward eliminating the disease to be uneven, and provided recommendations to address gaps and challenges. Continue reading -> WHA: Africa Takes Steps For Access To Medicines – Conference To Fight Fakes, Develop Local Production 23/05/2018 Catherine Saez A week after African ministers of health adopted a treaty for the establishment on the African Medicines Agency, an international conference held on the side of the World Health Assembly denounced the rampant and increasing issue of fake medicines in Africa, and the lack of adequate action and political will. The Benin president said Benin's efforts to fight traffickers is so far unsupported, and called developed countries to commit to the fight. Other speakers insisted on the importance of local production of medicines, and the need for biting legislation to defeat fake medicines. Continue reading -> 50 Years Of Global Health Progress – Interview With IFPMA Head Thomas Cueni 23/05/2018 William New Dr Tedros Adhanom Ghebreyesus, WHO Director-General in his inaugural speech at the World Health Assembly this week, explained that partnerships are a key strategy for the WHO to ensuring healthy lives and promoting well-being for all at all ages. He added that the WHO is engaging with the private sector as a crucial partner in achieving health for all. Thomas Cueni, IFPMA’s Director General, in an interview with Health Policy Watch on the occasion of the IFPMA’s 50-year anniversary, explains how the research-based biopharmaceutical industry together with IFPMA have contributed to the huge strides in health progress over 50 years. He explains the major leaps forward, setbacks and mistakes, as well as how industry is part of the solution, as "do-ers" and partners in global health progress. Cueni also talks about pricing and cost of R&D. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Top WHO Official On HIV/AIDS Gottfried Hirnschall: World Needs New Approaches To Deal With HIV/AIDS Challenges 23/07/2018 John Zarocostas As the 2018 International AIDS Conference kicks off in Amsterdam (23-27 July), Gottfried Hirnschall, Director of the HIV/AIDS Department and the Global Hepatitis Programme of the World Health Organization, discussed in a wide-ranging interview with John Zarocostas for Health Policy Watch the advances, setbacks, and challenges ahead in the global fight against the HIV/AIDS epidemic. On 18 July, a new report by UNAIDS warned that new infections are rising in around 50 countries, and that AIDS-related deaths are not falling fast enough and flat resources are threatening success. Dr Hirnschall leads the WHO's work in development and implementation of cutting-edge normative policies and guidance, and of technical support to countries to scale up national responses to HIV and hepatitis. He also oversees the Global Hepatitis Programme, which coordinates the organisation’s response to viral hepatitis. Hirnschall holds an MD from the University of Vienna, Austria, and an MPH from the Johns Hopkins Bloomberg School of Public Health. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> UN Debates Human Rights Issues Surrounding Mental And Physical Health Of Confined Persons 25/06/2018 Adithi Koushik The UN Human Rights Council session last week saw mental health placed at the forefront with the report of the Special Rapporteur on the Right to Health. Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Big Drop In AIDS-Related Deaths But Uneven Progress On Ending Disease, UN Says 14/06/2018 David Branigan Member states of the United Nations highlighted progress on combatting AIDS at a 12 June meeting of the General Assembly, with AIDS-related deaths reduced “from 1.5 million in 2010 to 1 million in 2016,” according to a UN report. But the report found progress toward eliminating the disease to be uneven, and provided recommendations to address gaps and challenges. Continue reading -> WHA: Africa Takes Steps For Access To Medicines – Conference To Fight Fakes, Develop Local Production 23/05/2018 Catherine Saez A week after African ministers of health adopted a treaty for the establishment on the African Medicines Agency, an international conference held on the side of the World Health Assembly denounced the rampant and increasing issue of fake medicines in Africa, and the lack of adequate action and political will. The Benin president said Benin's efforts to fight traffickers is so far unsupported, and called developed countries to commit to the fight. Other speakers insisted on the importance of local production of medicines, and the need for biting legislation to defeat fake medicines. Continue reading -> 50 Years Of Global Health Progress – Interview With IFPMA Head Thomas Cueni 23/05/2018 William New Dr Tedros Adhanom Ghebreyesus, WHO Director-General in his inaugural speech at the World Health Assembly this week, explained that partnerships are a key strategy for the WHO to ensuring healthy lives and promoting well-being for all at all ages. He added that the WHO is engaging with the private sector as a crucial partner in achieving health for all. Thomas Cueni, IFPMA’s Director General, in an interview with Health Policy Watch on the occasion of the IFPMA’s 50-year anniversary, explains how the research-based biopharmaceutical industry together with IFPMA have contributed to the huge strides in health progress over 50 years. He explains the major leaps forward, setbacks and mistakes, as well as how industry is part of the solution, as "do-ers" and partners in global health progress. Cueni also talks about pricing and cost of R&D. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> UN Debates Human Rights Issues Surrounding Mental And Physical Health Of Confined Persons 25/06/2018 Adithi Koushik The UN Human Rights Council session last week saw mental health placed at the forefront with the report of the Special Rapporteur on the Right to Health. Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Big Drop In AIDS-Related Deaths But Uneven Progress On Ending Disease, UN Says 14/06/2018 David Branigan Member states of the United Nations highlighted progress on combatting AIDS at a 12 June meeting of the General Assembly, with AIDS-related deaths reduced “from 1.5 million in 2010 to 1 million in 2016,” according to a UN report. But the report found progress toward eliminating the disease to be uneven, and provided recommendations to address gaps and challenges. Continue reading -> WHA: Africa Takes Steps For Access To Medicines – Conference To Fight Fakes, Develop Local Production 23/05/2018 Catherine Saez A week after African ministers of health adopted a treaty for the establishment on the African Medicines Agency, an international conference held on the side of the World Health Assembly denounced the rampant and increasing issue of fake medicines in Africa, and the lack of adequate action and political will. The Benin president said Benin's efforts to fight traffickers is so far unsupported, and called developed countries to commit to the fight. Other speakers insisted on the importance of local production of medicines, and the need for biting legislation to defeat fake medicines. Continue reading -> 50 Years Of Global Health Progress – Interview With IFPMA Head Thomas Cueni 23/05/2018 William New Dr Tedros Adhanom Ghebreyesus, WHO Director-General in his inaugural speech at the World Health Assembly this week, explained that partnerships are a key strategy for the WHO to ensuring healthy lives and promoting well-being for all at all ages. He added that the WHO is engaging with the private sector as a crucial partner in achieving health for all. Thomas Cueni, IFPMA’s Director General, in an interview with Health Policy Watch on the occasion of the IFPMA’s 50-year anniversary, explains how the research-based biopharmaceutical industry together with IFPMA have contributed to the huge strides in health progress over 50 years. He explains the major leaps forward, setbacks and mistakes, as well as how industry is part of the solution, as "do-ers" and partners in global health progress. Cueni also talks about pricing and cost of R&D. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
UN Debates Human Rights Issues Surrounding Mental And Physical Health Of Confined Persons 25/06/2018 Adithi Koushik The UN Human Rights Council session last week saw mental health placed at the forefront with the report of the Special Rapporteur on the Right to Health. Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Big Drop In AIDS-Related Deaths But Uneven Progress On Ending Disease, UN Says 14/06/2018 David Branigan Member states of the United Nations highlighted progress on combatting AIDS at a 12 June meeting of the General Assembly, with AIDS-related deaths reduced “from 1.5 million in 2010 to 1 million in 2016,” according to a UN report. But the report found progress toward eliminating the disease to be uneven, and provided recommendations to address gaps and challenges. Continue reading -> WHA: Africa Takes Steps For Access To Medicines – Conference To Fight Fakes, Develop Local Production 23/05/2018 Catherine Saez A week after African ministers of health adopted a treaty for the establishment on the African Medicines Agency, an international conference held on the side of the World Health Assembly denounced the rampant and increasing issue of fake medicines in Africa, and the lack of adequate action and political will. The Benin president said Benin's efforts to fight traffickers is so far unsupported, and called developed countries to commit to the fight. Other speakers insisted on the importance of local production of medicines, and the need for biting legislation to defeat fake medicines. Continue reading -> 50 Years Of Global Health Progress – Interview With IFPMA Head Thomas Cueni 23/05/2018 William New Dr Tedros Adhanom Ghebreyesus, WHO Director-General in his inaugural speech at the World Health Assembly this week, explained that partnerships are a key strategy for the WHO to ensuring healthy lives and promoting well-being for all at all ages. He added that the WHO is engaging with the private sector as a crucial partner in achieving health for all. Thomas Cueni, IFPMA’s Director General, in an interview with Health Policy Watch on the occasion of the IFPMA’s 50-year anniversary, explains how the research-based biopharmaceutical industry together with IFPMA have contributed to the huge strides in health progress over 50 years. He explains the major leaps forward, setbacks and mistakes, as well as how industry is part of the solution, as "do-ers" and partners in global health progress. Cueni also talks about pricing and cost of R&D. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Big Drop In AIDS-Related Deaths But Uneven Progress On Ending Disease, UN Says 14/06/2018 David Branigan Member states of the United Nations highlighted progress on combatting AIDS at a 12 June meeting of the General Assembly, with AIDS-related deaths reduced “from 1.5 million in 2010 to 1 million in 2016,” according to a UN report. But the report found progress toward eliminating the disease to be uneven, and provided recommendations to address gaps and challenges. Continue reading -> WHA: Africa Takes Steps For Access To Medicines – Conference To Fight Fakes, Develop Local Production 23/05/2018 Catherine Saez A week after African ministers of health adopted a treaty for the establishment on the African Medicines Agency, an international conference held on the side of the World Health Assembly denounced the rampant and increasing issue of fake medicines in Africa, and the lack of adequate action and political will. The Benin president said Benin's efforts to fight traffickers is so far unsupported, and called developed countries to commit to the fight. Other speakers insisted on the importance of local production of medicines, and the need for biting legislation to defeat fake medicines. Continue reading -> 50 Years Of Global Health Progress – Interview With IFPMA Head Thomas Cueni 23/05/2018 William New Dr Tedros Adhanom Ghebreyesus, WHO Director-General in his inaugural speech at the World Health Assembly this week, explained that partnerships are a key strategy for the WHO to ensuring healthy lives and promoting well-being for all at all ages. He added that the WHO is engaging with the private sector as a crucial partner in achieving health for all. Thomas Cueni, IFPMA’s Director General, in an interview with Health Policy Watch on the occasion of the IFPMA’s 50-year anniversary, explains how the research-based biopharmaceutical industry together with IFPMA have contributed to the huge strides in health progress over 50 years. He explains the major leaps forward, setbacks and mistakes, as well as how industry is part of the solution, as "do-ers" and partners in global health progress. Cueni also talks about pricing and cost of R&D. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
CDC Director Redfield: Long-Term Investment In Global Health Security Most Critical 14/06/2018 William New WASHINGTON, DC -- Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example. Continue reading -> Big Drop In AIDS-Related Deaths But Uneven Progress On Ending Disease, UN Says 14/06/2018 David Branigan Member states of the United Nations highlighted progress on combatting AIDS at a 12 June meeting of the General Assembly, with AIDS-related deaths reduced “from 1.5 million in 2010 to 1 million in 2016,” according to a UN report. But the report found progress toward eliminating the disease to be uneven, and provided recommendations to address gaps and challenges. Continue reading -> WHA: Africa Takes Steps For Access To Medicines – Conference To Fight Fakes, Develop Local Production 23/05/2018 Catherine Saez A week after African ministers of health adopted a treaty for the establishment on the African Medicines Agency, an international conference held on the side of the World Health Assembly denounced the rampant and increasing issue of fake medicines in Africa, and the lack of adequate action and political will. The Benin president said Benin's efforts to fight traffickers is so far unsupported, and called developed countries to commit to the fight. Other speakers insisted on the importance of local production of medicines, and the need for biting legislation to defeat fake medicines. Continue reading -> 50 Years Of Global Health Progress – Interview With IFPMA Head Thomas Cueni 23/05/2018 William New Dr Tedros Adhanom Ghebreyesus, WHO Director-General in his inaugural speech at the World Health Assembly this week, explained that partnerships are a key strategy for the WHO to ensuring healthy lives and promoting well-being for all at all ages. He added that the WHO is engaging with the private sector as a crucial partner in achieving health for all. Thomas Cueni, IFPMA’s Director General, in an interview with Health Policy Watch on the occasion of the IFPMA’s 50-year anniversary, explains how the research-based biopharmaceutical industry together with IFPMA have contributed to the huge strides in health progress over 50 years. He explains the major leaps forward, setbacks and mistakes, as well as how industry is part of the solution, as "do-ers" and partners in global health progress. Cueni also talks about pricing and cost of R&D. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Big Drop In AIDS-Related Deaths But Uneven Progress On Ending Disease, UN Says 14/06/2018 David Branigan Member states of the United Nations highlighted progress on combatting AIDS at a 12 June meeting of the General Assembly, with AIDS-related deaths reduced “from 1.5 million in 2010 to 1 million in 2016,” according to a UN report. But the report found progress toward eliminating the disease to be uneven, and provided recommendations to address gaps and challenges. Continue reading -> WHA: Africa Takes Steps For Access To Medicines – Conference To Fight Fakes, Develop Local Production 23/05/2018 Catherine Saez A week after African ministers of health adopted a treaty for the establishment on the African Medicines Agency, an international conference held on the side of the World Health Assembly denounced the rampant and increasing issue of fake medicines in Africa, and the lack of adequate action and political will. The Benin president said Benin's efforts to fight traffickers is so far unsupported, and called developed countries to commit to the fight. Other speakers insisted on the importance of local production of medicines, and the need for biting legislation to defeat fake medicines. Continue reading -> 50 Years Of Global Health Progress – Interview With IFPMA Head Thomas Cueni 23/05/2018 William New Dr Tedros Adhanom Ghebreyesus, WHO Director-General in his inaugural speech at the World Health Assembly this week, explained that partnerships are a key strategy for the WHO to ensuring healthy lives and promoting well-being for all at all ages. He added that the WHO is engaging with the private sector as a crucial partner in achieving health for all. Thomas Cueni, IFPMA’s Director General, in an interview with Health Policy Watch on the occasion of the IFPMA’s 50-year anniversary, explains how the research-based biopharmaceutical industry together with IFPMA have contributed to the huge strides in health progress over 50 years. He explains the major leaps forward, setbacks and mistakes, as well as how industry is part of the solution, as "do-ers" and partners in global health progress. Cueni also talks about pricing and cost of R&D. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHA: Africa Takes Steps For Access To Medicines – Conference To Fight Fakes, Develop Local Production 23/05/2018 Catherine Saez A week after African ministers of health adopted a treaty for the establishment on the African Medicines Agency, an international conference held on the side of the World Health Assembly denounced the rampant and increasing issue of fake medicines in Africa, and the lack of adequate action and political will. The Benin president said Benin's efforts to fight traffickers is so far unsupported, and called developed countries to commit to the fight. Other speakers insisted on the importance of local production of medicines, and the need for biting legislation to defeat fake medicines. Continue reading -> 50 Years Of Global Health Progress – Interview With IFPMA Head Thomas Cueni 23/05/2018 William New Dr Tedros Adhanom Ghebreyesus, WHO Director-General in his inaugural speech at the World Health Assembly this week, explained that partnerships are a key strategy for the WHO to ensuring healthy lives and promoting well-being for all at all ages. He added that the WHO is engaging with the private sector as a crucial partner in achieving health for all. Thomas Cueni, IFPMA’s Director General, in an interview with Health Policy Watch on the occasion of the IFPMA’s 50-year anniversary, explains how the research-based biopharmaceutical industry together with IFPMA have contributed to the huge strides in health progress over 50 years. He explains the major leaps forward, setbacks and mistakes, as well as how industry is part of the solution, as "do-ers" and partners in global health progress. Cueni also talks about pricing and cost of R&D. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
50 Years Of Global Health Progress – Interview With IFPMA Head Thomas Cueni 23/05/2018 William New Dr Tedros Adhanom Ghebreyesus, WHO Director-General in his inaugural speech at the World Health Assembly this week, explained that partnerships are a key strategy for the WHO to ensuring healthy lives and promoting well-being for all at all ages. He added that the WHO is engaging with the private sector as a crucial partner in achieving health for all. Thomas Cueni, IFPMA’s Director General, in an interview with Health Policy Watch on the occasion of the IFPMA’s 50-year anniversary, explains how the research-based biopharmaceutical industry together with IFPMA have contributed to the huge strides in health progress over 50 years. He explains the major leaps forward, setbacks and mistakes, as well as how industry is part of the solution, as "do-ers" and partners in global health progress. Cueni also talks about pricing and cost of R&D. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy